(Q44343291)

reason for preferred rank

2 December 2017

title

Effects of NMDA receptor antagonists on acute μ-opioid analgesia in the rat (English)

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

27 March 2024

Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592689

27 March 2024

0 references

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

27 March 2024

author name string

Karen E. Redwine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592689

27 March 2024

Keith A. Trujillo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592689

27 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0091305703002533?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

https://api.elsevier.com/content/article/PII:S0091305703002533?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Pharmacology, Biochemistry and Behavior

27 March 2024

published in

1 reference

2 December 2017

volume

76

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

361-372

1 reference

New approaches to pain control in patients with cancer

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats

27 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Low-dose subcutaneous ketamine infusion and morphine tolerance.

27 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval

27 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Tolerance to the antinociceptive effect of morphine in the spinal rat

27 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice

27 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.

27 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance.

27 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor

27 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats

27 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice

27 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

27 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Behavioral interactions caused by combined administration of morphine and MK-801 in rats.

27 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination

27 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain

27 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Evidence for opiate-activated NMDA processes masking opiate analgesia in rats

27 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine

27 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat in the rat brain

27 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The glutamate receptor ion channels

27 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.

27 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents

27 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Dextromethorphan attenuates and reverses analgesic tolerance to morphine

27 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

27 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance

27 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Long-term safety of MorphiDex

27 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.

27 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

27 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

MK-801 inhibits the development of morphine tolerance at spinal sites.

27 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

27 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats

27 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy.

27 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients

27 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist

27 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats

27 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems

27 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia.

27 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Blockade of morphine-induced analgesia and tolerance in mice by MK-801.

27 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist

27 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test

27 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine

27 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

27 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

27 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

27 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

27 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats

27 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study

27 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging

27 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

27 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Glutamate receptors in the mammalian central nervous system

27 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats

27 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

27 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

27 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

27 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality

27 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists

27 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist

27 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study

27 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

27 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

Subunit- and site-specific pharmacology of the NMDA receptor channel

27 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.PBB.2003.08.009

27 March 2024

Identifiers

1 reference

2 December 2017

1 reference